Preventing physician medication mix-ups by reporting them

Dec 03, 2010

The most frequent contributors to medication errors and adverse drug events in busy primary care practice offices are communication problems and lack of knowledge, according to a study of a prototype web-based medication error and adverse drug event reporting system.

Research on the use of MEADERS ( and Adverse Drug Event Reporting System), developed by investigators from the Regenstrief Institute and Indiana University School of Medicine led by Atif Zafar, M.D., appears in the November/December 2010 issue of the Annals of Family Medicine.

"We as physicians have a responsibility to make good decisions and to translate those decisions into safe and effective care. If we make a mistake we need to learn from the mistake and prevent it from reoccurring. We found this first generation reporting system to be popular with physicians and others in their offices, in spite of time pressures and a culture that does not support admitting mistakes," said William M. Tierney, M.D., president and CEO of the Regenstrief Institute. Dr. Tierney, who is also associate dean for clinical effectiveness research at the IU School of Medicine, is a co-developer of MEADERS and is the senior author of the study.

Urban, suburban and rural primary care practices in California, Connecticut, Oregon and Texas used MEADERS for 10 weeks, submitting 507 confidential event reports. The average time spent reporting an event was a little over four minutes. Seventy percent of reports included medication errors only. Only two percent included both medication errors and adverse drug events.

"Our study has created what is now the largest database of medication errors in primary care," said Dr. Tierney. "It taught us many real world lessons that we are applying to the next generation reporting system currently under development. It also informed the practices of problems encountered by the doctors, practices and patients in the safe and effective use of drugs. Only by uncovering such problems can they be dealt with to prevent future events. MEADERS allowed a safe and secure means whereby the practices can report such problems."

Medications used for cardiovascular, central nervous system (including pain killers), endocrine diseases (mainly diabetes), and antibiotics were most often associated with the events reported in MEADERS.

Medication errors were equally divided among ordering medications, implementing prescription orders, errors by patients receiving the medications and documentation errors. There was no harm in two-thirds of the patients, documented harm in 11 percent, and nothing mentioned for 20 percent.

"We demonstrated that it is feasible to deploy a web-based medication event that clinicians and staff can understand and use in busy primary care practices. The real challenge is to demonstrate that event reporting is sustainable and that the data from event reporting can be used in an ongoing way to identify and to correct systems problems to reduce medication errors, adverse drug events, hospital admissions and patient harm," said Dr. Tierney.

Explore further: FDA OKs Cubist antibiotic for serious infections

Provided by Indiana University School of Medicine

2 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Tech-check-tech

Jan 04, 2007

Regulation set to take effect tomorrow, Jan. 5, 2007, is designed to reduce medication errors in California hospitals and free pharmacists for greater involvement in direct patient care rather than in non-discretionary (clerical) ...

Physicians click their way to better prescriptions

Mar 10, 2010

Is it time for all community-based doctors to turn to e-prescribing to cut down on the number of medication errors? According to Rainu Kaushal and colleagues from the Weill Cornell Medical College in New York, electronic ...

Recommended for you

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.